• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX FX OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number CX-FX05RW
Device Problem Increase in Pressure (1491)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/26/2018
Event Type  malfunction  
Manufacturer Narrative
Implanted date: device was not implanted.Explanted date: device was not explanted.The actual device was returned for evaluation.Visual inspection revealed no anomalies in appearance.Saline solution was let to flow through the actual device by gravity.Another visual inspection of the actual device did not find any clot formation visible to the unaided eye.The actual device was fixed with saline solution containing glutaraldehyde solution.The housing and filter were removed from the oxygenator module.Visual inspection of the filter did not find any clot formation visible to the unaided eye either on the outer or inner surface.Visual inspection of the oxygenator module, after the housing and filter having been removed from it, did not find any clot formation visible to the unaided eye on the fiber.The fiber winding was confirmed to be in the normal state.The fiber layer was removed from the winding in increments of 2mm and each layer was subjected to visual inspection.There was no clot formation visible to the naked eye on the fiber.The fiber and the outer cylinder were removed from the heat exchanger module and the inside of the heat exchanger module was subjected to visual and magnifying inspections.Clot formation was found at the bottom of the device.The filter removed from the oxygenator module was inspected under magnification.No clot formation was confirmed.The fiber layers removed during the test in above were inspected under magnification.No clot formation was confirmed.The filter was inspected under electron microscope.The formation of the fibrin net and the adhesion of the erythrocyte components, including red blood cells, deformed red blood cells (echinocyte) and platelets were found on the surface.Electron microscopic inspection of the fiber on each layer on the upper side of the fiber winding obtained in above did not find clot formation which could have contributed to the reported pressure rise.The clot found to have formed at the bottom of the heat exchanger module was sampled and inspected under microscope.The adhesion of the erythrocyte components and the formation of the fibrin net were found.A review of the device history record of the involved product code/lot number combination revealed no findings.There is no evidence that this event was related to a device defect or malfunction.During the inspection of the actual device, clots were found to have formed at the bottom of the heat exchanger module.However, the exact cause of the reported event cannot be definitively determined based on the available information.(b)(4).
 
Event Description
The user facility reported after priming with bicarbon (bicarbonate ringer's solution) and heparin, blood for transfusion was put into a competitor's reservoir and ultrafiltration was performed.After 1-hour circulation in the recirculation line, thrombus formation was found in the competitor's reservoir and the pressure inside the actual sample increased.Both the reservoir and the actual sample were changed out.The procedure outcome was reported to be unknown.The patient was not harmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX FX OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
mark vornheder
reg. no. 2243441
950 elkton blvd
elkton, MD 21921
MDR Report Key7977128
MDR Text Key124665097
Report Number9681834-2018-00187
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K071572
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/18/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2021
Device Catalogue NumberCX-FX05RW
Device Lot Number180511
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/03/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/27/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/11/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-